{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:37:43Z","timestamp":1761172663822,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.mycmed.2024.101464","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T02:51:22Z","timestamp":1707533482000},"page":"101464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro determination of the combination of ciclopirox and terbinafine in the treatment of dermatophytosis"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2123-8280","authenticated-orcid":false,"given":"B\u00e1rbara","family":"da Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Pippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Agostineto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Meneghello","family":"Fuentefria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mycmed.2024.101464_bib0001","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1590\/abd1806-4841.20142569","article-title":"Clinical, epidemiological, and therapeutic profile of dermatophytosis","volume":"89","author":"Pires","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.mycmed.2024.101464_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.fgb.2019.103255","article-title":"Antifungal resistance in dermatophytes: recent trends and therapeutic implications","author":"Khurana","year":"2019","journal-title":"Fung GenetBiol"},{"key":"10.1016\/j.mycmed.2024.101464_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/lam.12820","article-title":"Antifungals discovery: an insight into new strategies to combat antifungal resistance","volume":"66","author":"Fuentefria","year":"2017","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.mycmed.2024.101464_bib0004","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019802","article-title":"Fungi on the skin: dermatophytes and malassezia","volume":"4","author":"White","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.mycmed.2024.101464_bib0005","first-page":"e17149","article-title":"In Vitro additive effect on griseofulvin and terbinafine combinations against multidrug-resistant dermatophytes","volume":"54","author":"Lana","year":"2018","journal-title":"Braz J Pharmaceut Sci"},{"issue":"3","key":"10.1016\/j.mycmed.2024.101464_bib0006","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5455\/medarh.2015.69.173-176","article-title":"Treatment of onychomycosis - a clinical study","volume":"69","author":"Pajaziti","year":"2015","journal-title":"Med Arch"},{"issue":"2","key":"10.1016\/j.mycmed.2024.101464_bib0007","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/pde.14524","article-title":"Fingernail onychomycosis caused by Microsporum canis in a teenager","volume":"38","author":"Limphoka","year":"2021","journal-title":"Pediatr Dermatol"},{"year":"2008","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard \u2013 third edition. clsi document M27-A3","key":"10.1016\/j.mycmed.2024.101464_bib0008"},{"issue":"No. 3","key":"10.1016\/j.mycmed.2024.101464_bib0009","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1016\/j.mycmed.2024.101464_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.mycmed.2024.101464_bib0011","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2133.1996.d01-759.x","article-title":"Proximal subungual onychomycosis due to Microsporum canis","volume":"134","author":"Piraccini","year":"1996","journal-title":"Br J Dermatol"},{"issue":"3\u20134","key":"10.1016\/j.mycmed.2024.101464_bib0012","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1439-0507.2001.00623.x","article-title":"Case report. Onychomycosis due to Microsporum canis","volume":"44","author":"Romano","year":"2001","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.mycmed.2024.101464_bib0013","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00296-002-0178-y","article-title":"Proximal white subungual onychomycosis caused by Microsporum canis in systemic lupus erythematosus","volume":"21","author":"Tlacuilo-Parra","year":"2002","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.mycmed.2024.101464_bib0014","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1439-0507.2006.01248.x","article-title":"Dystrophic onychomycosis due to Microsporum gypseum","volume":"49","author":"Romano","year":"2006","journal-title":"Mycoses"},{"issue":"11\u201312","key":"10.1016\/j.mycmed.2024.101464_bib0015","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s11046-017-0194-9","article-title":"Human Infections with Microsporum gypseum Complex (Nannizzia gypsea) in Slovenia","volume":"182","author":"Dolenc-Volj\u010d","year":"2017","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.mycmed.2024.101464_bib0016","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/21505594.2016.1257457","article-title":"New facets of antifungal therapy","volume":"8","author":"Chang","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.mycmed.2024.101464_bib0017","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/jac\/dkl392","article-title":"Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species","volume":"58","author":"O'Shaughnessy","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2024.101464_bib0018","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/AAC.48.3.970-978.2004","article-title":"In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus","volume":"48","author":"Dannaoui","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2024.101464_bib0019","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/myc.13127","article-title":"In vitro antidermatophytic synergism of double and triple combination of clioquinol with ciclopirox and terbinafine","volume":"63","author":"da Costa","year":"2020","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.mycmed.2024.101464_bib0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2133.2003.05418.x","article-title":"In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity","volume":"149","author":"Gupta","year":"2003","journal-title":"Brit J Dermatol"},{"issue":"6","key":"10.1016\/j.mycmed.2024.101464_bib0021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0378-6323.37056","article-title":"An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8 % or topical amorolfine hydrochloride 5 % in the treatment of onychomycosis","volume":"73","author":"Jaiswal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5\u20136","key":"10.1016\/j.mycmed.2024.101464_bib0022","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/09546630500420183","article-title":"Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis","volume":"16","author":"Avner","year":"2005","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.mycmed.2024.101464_bib0023","first-page":"389","article-title":"Optimizing topical therapy for onychomycosis: the importance of patient education","volume":"102","author":"Lipner","year":"2018","journal-title":"Cutis"},{"issue":"5","key":"10.1016\/j.mycmed.2024.101464_bib0024","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s13555-020-00420-9","article-title":"Ciclopirox Hydroxypropyl Chitosan (HPCH) nail lacquer: a review of its use in onychomycosis","volume":"10","author":"Piraccini","year":"2020","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523324000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523324000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:23:00Z","timestamp":1761110580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523324000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1156523324000052"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2024.101464","relation":{},"ISSN":["1156-5233"],"issn-type":[{"type":"print","value":"1156-5233"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro determination of the combination of ciclopirox and terbinafine in the treatment of dermatophytosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2024.101464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SFMM. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101464"}}